Skip to content

PEG ratio at other companies

Biogen logo
BiogenBIIB
0.4×
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
0.4×+0.1×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.2×
Royalty Pharma logo
Royalty PharmaRPRX
0.3×

Other financials

Income statement

See full
Revenue$204.9M+69.6%
Gross profit$171.4M+62.8%
Operating income$34.8M+304%
Net income$19.8M+291%
EPS (diluted)$0.12+300%

Balance sheet

See full
Cash & equivalents$442.2M+235%
Total debt$753.6M+197%
Total equity$583.1M+146%
Total assets$1.5B+133%

Cash flow

See full
Operating cash flow-$17.9M+37.7%
CapEx$51.0K+104%
Free cash flow-$17.9M+37.6%

Valuation

See full
Market cap$8.15B-14.3%
Enterprise value$8.46B-11.1%
P/E17.6×-225×
P/S11.6×-13.0×

Profitability

See full
Gross margin83.1%-4.4pp
Operating margin21.3%+5.9pp
Net margin66%+55.8pp
FCF margin-6,328.4%+4,773pp

Returns & leverage

See full
Return on equity112.6%+92.9pp
Debt / equity1.3×+0.2×
Current ratio5.8×+1.8×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

Based on the most recent quarter.

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TG Therapeutics's PEG ratio?
TG Therapeutics (TGTX) reported PEG ratio of 0× in Q1 2026.
What does PEG ratio mean?
The P/E ratio adjusted for how fast earnings are growing.
How do you interpret PEG ratio?
Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
How does PEG ratio compare across companies?
A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.